InvestSMART

Acrux Limited (ASX: ACR) - Announcements

Current share price for ACR : $0.010 0.001 (9.09%)+

ASX company news and announcements for Acrux Limited (ACR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acrux Limited (ACR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acrux Limited (ACR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acrux Limited (ACR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Notice of Annual General Meeting/Proxy Form 23 Oct 2026 8:20AM $0.011 $0.010 fallen by 9.09%
$6 Application for quotation of securities - ACR 19 Oct 2026 3:00PM $0.011 $0.010 fallen by 9.09%
$6 Quarterly Activities/Appendix 4C Cash Flow Report 19 Oct 2026 9:39AM $0.012 $0.010 fallen by 16.67%
$6 FDA clears regulatory pathway for Female Testosterone MDTS 12 Oct 2026 9:30AM $0.011 $0.010 fallen by 9.09%
$6 Webinar, Monday 12 October 2026 - Female Testosterone MDTS 9 Oct 2026 8:51AM $0.010 $0.010 fallen by 0%
$6 Acrux has received $1.977m RDTI rebate for FY26 2 Oct 2026 8:22AM $0.010 $0.010 fallen by 0%
$6 Application for quotation of securities - ACR 24 Sep 2026 8:29AM $0.010 $0.010 risen by 5.26%
$6 AGM date, closing date for director nominations 14 Sep 2026 9:21AM $0.011 $0.010 fallen by 9.09%
$6 Appendix 3Y Brooke 14 Sep 2026 9:18AM $0.011 $0.010 fallen by 9.09%
$6 Application for quotation of securities - ACR 14 Sep 2026 9:17AM $0.011 $0.010 fallen by 9.09%
$6 Appendix 3Y Brooke 3 Sep 2026 9:16AM $0.011 $0.010 fallen by 9.09%
$6 Appendix 3Y Warmbrunn 3 Sep 2026 9:16AM $0.011 $0.010 fallen by 9.09%
$6 Appendix 3Y Oldham 3 Sep 2026 9:16AM $0.011 $0.010 fallen by 9.09%
$6 Appendix 3Y Brumley 3 Sep 2026 9:16AM $0.011 $0.010 fallen by 9.09%
$6 Appendix 3Y Dobinson 3 Sep 2026 9:15AM $0.011 $0.010 fallen by 9.09%
$6 Application for quotation of securities - ACR 3 Sep 2026 9:15AM $0.011 $0.010 fallen by 9.09%
$6 Application for quotation of securities - ACR 3 Sep 2026 9:08AM $0.011 $0.010 fallen by 9.09%
$6 FY26 Appendix 4G and Corporate Governance Statement 26 Aug 2026 9:28AM $0.010 $0.010 fallen by 0%
$6 FY26 Annual Report and Appendix 4E 26 Aug 2026 9:27AM $0.010 $0.010 fallen by 0%
$6 Acrux appoints Chief Medical Officer 24 Aug 2026 9:44AM $0.010 $0.010 fallen by 0%
$6 Webinar invitation for 17 August 2026, 11am 14 Aug 2026 9:50AM $0.010 $0.010 fallen by 0%
$6 Application for quotation of securities - ACR 13 Aug 2026 9:31AM $0.009 $0.010 risen by 11.11%
$6 Notification of cessation of securities - ACR 13 Aug 2026 9:27AM $0.009 $0.010 risen by 11.11%
$6 Investor Presentation - Female Testosterone for HSDD 6 Aug 2026 9:02AM $0.011 $0.010 fallen by 9.09%
$6 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2026 10:07AM $0.010 $0.010 fallen by 0%

1 - 25 of 716 results

Page 1 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.